With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.
General procedure: The precursors were synthesized according to a previously reportedmethod. A solution of [RuCl2(eta6-C10H14)]2 (0.200 g, 0.31 mmol) with an excess of the desired N-N ligand (0.75 mmol) in methanol (25 mL) was stirred for 1 h. NH4PF6 (0.30 g; 1.00 mmol) was added to this solution, also dissolved in methanol (5 mL), and the mixture was stirred at room temperature for 1 h longer. The orange-yellow solid that precipitated was filtered off, washed with cold methanol and diethyl ether, and dried under vacuum.
1662-01-7 4,7-Diphenyl-1,10-phenanthroline 72812, acatalyst-ligand compound, is more and more widely used in various.
Reference£º
Article; Colina-Vegas, Legna; Villarreal, Wilmer; Navarro, Maribel; De Oliveira, Clayton Rodrigues; Graminha, Angelica E.; Maia, Pedro Ivo Da S.; Deflon, Victor M.; Ferreira, Antonio G.; Cominetti, Marcia Regina; Batista, Alzir A.; Journal of Inorganic Biochemistry; vol. 153; (2015); p. 150 – 161;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI